MEDANTA (Global Health) (Large Cap - Potential Multibagger) Share Target 2026, 2027 To 2035
|
Global Health Limited |
|||
|
Price: ₹1,219.90 (-1.23%) | ||
| 52 Week Low: ₹956.00 52 Week High: ₹1,456.50 |
|||
| Market Capital: 29,861.85 Crore (Large-cap) | |||
| Healthcare -> Medical Care Facilities | |||
MEDANTA (Global Health) Stock Comparison: MEDANTA (Global Health) vs Narayana Hrudayalaya | MEDANTA (Global Health) vs Krishna Institute of Medical Sciences | MEDANTA (Global Health) vs Aster Healthcare | MEDANTA (Global Health) vs Gland Pharma | MEDANTA (Global Health) vs Syngene International | MEDANTA (Global Health) vs J.B. Chemicals & Pharma |
|||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: MEDANTA (Global Health) Share Price Target For 2026
- 1.1.1: MEDANTA (Global Health) Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: MEDANTA (Global Health) Share Price Target For 2027
- 1.2.1: MEDANTA (Global Health) Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: MEDANTA (Global Health) Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: MEDANTA (Global Health) Brief Company Overview
- 4: MEDANTA (Global Health) Financial Performance
- 4.0.1: Is MEDANTA (Global Health) A Good Buy For Long Term?
MEDANTA (Global Health), a Large Cap company in the Medical Care Facilities Industry has delivered 198.2% returns in 5-year showing 11.4% quarterly revenue growth with 14.4% profit margin, making it a potential Multibagger.
To predict the MEDANTA (Global Health)'s future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
MEDANTA (Global Health) Share Price Target For 2026
The line chart displays the monthly closing prices of MEDANTA (Global Health) with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for MEDANTA (Global Health) shares in 2026, see the table below.
MEDANTA (Global Health) Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1313.45 (+7.66%) | Volatility: ATR T1 |
| 2026 Target 2 | 1263.53 (+3.57%) | Volatility: BB Upper |
| 2026 Target 1 | 1224.20 (+0.35%) | Trend: EMA9 |
| Current Price | 1219.90 | MEDANTA (Global Health)'s share price as of 15 Jun 2026 |
| Stop Loss 1 | 1206.25 (-1.12%) | 50.00% Weekly Fib Retrace |
| Stop Loss 2 | 1199.24 (-1.7%) | Trend: SMA200 |
| Stop Loss 3 | 1180.90 (-3.2%) | Volatility: BB Lower |
Short-Term Technical Outlook
Current Technical Position: MEDANTA (Global Health) is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹1166.52 serves as the nearest technical reference point.
Historical Returns: 3-month: +17.21% | 6-month: +6.24% | 1-year: +4.14%
MEDANTA (Global Health) Share Price Target For 2027
The line chart displays the monthly closing prices of MEDANTA (Global Health) with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for MEDANTA (Global Health) shares in 2027, see the table below.
MEDANTA (Global Health) Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 1313.45 (+7.66%) | Volatility: ATR T1 |
| 2027 Target 2 | 1263.53 (+3.57%) | Volatility: BB Upper |
| 2027 Target 1 | 1224.20 (+0.35%) | Trend: EMA9 |
| Current Price | 1219.90 | MEDANTA (Global Health)'s share price as of 15 Jun 2026 |
| Stop Loss 1 | 1206.25 (-1.12%) | 50.00% Weekly Fib Retrace |
| Stop Loss 2 | 1199.24 (-1.7%) | Trend: SMA200 |
| Stop Loss 3 | 1180.90 (-3.2%) | Volatility: BB Lower |
Long-Term Technical Outlook
52-Week Range Analysis: MEDANTA (Global Health) is currently trading at 52.7% of its 52-week range (₹956 - ₹1456.5).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +4.14% | 3-year: +90.43% | 5-year: +198.23%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
MEDANTA (Global Health) Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,219.90 | ||
| 2026 | ₹1,464.88 | +20.08197393229% | ₹1,486.85 |
| 2027 | ₹1,941.55 | +32.539866746764% | ₹1,970.67 |
| 2028 | ₹2,334.40 | +20.233833792588% | ₹2,369.42 |
| 2029 | ₹2,957.14 | +26.676662097327% | ₹3,001.50 |
| 2030 | ₹3,726.43 | +26.014662816099% | ₹3,782.33 |
| 2031 | ₹4,475.62 | +20.10476515056% | ₹4,542.75 |
| 2032 | ₹5,649.15 | +26.220501293676% | ₹5,733.89 |
| 2033 | ₹6,607.33 | +16.961489781649% | ₹6,706.44 |
| 2034 | ₹8,498.22 | +28.618065088319% | ₹8,625.69 |
| 2035 | ₹10,162.92 | +19.588808009207% | ₹10,315.36 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
MEDANTA (Global Health) Brief Company Overview
Global Health Limited: Providing Comprehensive Healthcare in India Global Health Limited, established in 2004, is a leading healthcare provider in India operating a network of five hospitals under the Medanta brand. Based in New Delhi, the company offers a diverse range of...
healthcare services, including: Lung transplant Mother and child care Oncology Orthopaedics Urology Psychiatry Ayurvedic medicine Global Health Limited is renowned for its commitment to providing high-quality healthcare services. The company's state-of-the-art facilities and experienced medical professionals ensure patients receive comprehensive and compassionate care.MEDANTA (Global Health) Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 28,786.89 Crore | Market valuation of MEDANTA (Global Health)'s shares. |
| Revenue (TTM) | 3,356.6 Crore | Total revenue generated by MEDANTA (Global Health) over the past twelve months. |
| Net Income (TTM) | +482.46 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 16.22% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 14.37% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+11.4% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+4.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
27.59 | Company's total debt divided by total shareholder equity. |
| Total Debt | 801.86 Crore | Sum of MEDANTA (Global Health)'s current & long-term financial obligations. |
| Total Cash | 1,175.28 Crore | Total amount of liquid funds available to MEDANTA (Global Health). |
Is MEDANTA (Global Health) A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
